FDA Approves Drug Jakafi To Treat Chronic Bone Marrow Disorder

December 5, 2014 6:19 PM

2 0

The U.S. Food and Drug Administration (FDA) approved a new use for the drug Jakafi (ruxolitinib) to treat patients for polycythemia vera, a chronic bone marrow disease. This is the first drug approved by the FDA for this condition.

The U.S. Food and Drug Administration (FDA) approved a new use for the drug Jakafi (ruxolitinib) to treat patients for polycythemia vera, a chronic bone marrow disease. This is the first drug approved by the FDA for this condition.

Read more

To category page

Loading...